Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Diagnostics (Basel, Switzerland)|May 24, 2024
Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 TumorsAnne Menz, Nora Lony, Maximilian Lennartz, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 21, 2022
Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumorsMaximilian Lennartz, Verena Sofia Ullmann, Natalia Gorbokon, et al.Experimental and Molecular Pathology|November 26, 2025
Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancerVictoria Chirico, Tabea Lenkeit, Seyma Büyücek, et al.Biomedicines|July 29, 2025
Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 TumorsMaria Christina Tsourlakis, Simon Kind, Sebastian Dwertmann Rico, et al.Cancers|December 17, 2024
Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 TumorsKristina Jansen, Lara Kornfeld, Maximilian Lennartz, et al.BMC Cancer|July 3, 2024
KLK7 expression in human tumors: a tissue microarray study on 13,447 tumorsSimon Kind, Carolina Palacios Castillo, Ria Schlichter, et al.Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.Virchows Archiv : an International Journal of Pathology|February 17, 2026
Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor typesFlorian Viehweger, Paul Wirth, Natalia Gorbokon, et al.Virchows Archiv : an International Journal of Pathology|June 15, 2025
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumorsViktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, et al.Diagnostics (Basel, Switzerland)|August 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor PhenotypeViktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis, et al.Pageof 4